35
Trellis Bioscience raises $22.89M under Reg D 506(b) in Redwood City
Company raise · Open-ended · Offering Indefinite · Sold $22.9M · REDWOOD CITY, CA · filed 2026-10-21
40
Trellis Bioscience, Inc. raises $6.1M under Reg D
Company raise · Open-ended · REDWOOD CITY, CA · Form D filed 2026-05-15
First raise on EDGAR
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Stefan Ryser | President and Chief Executive Officer |
| Geoff Dillon | Chief Business Officer |
| Larry Kauvar | Chief Science Officer |
| Elisabeth Whitney | Chief Operating Officer |
| Nora Mende | Chief Financial Officer |
Signed by Stefan Ryser, President and Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
35
Trellis Bioscience raises $4.09M in indefinite offering under Reg D 506(b)
Company raise · Open-ended · Offering Indefinite · Sold $4.1M · REDWOOD CITY, CA · filed 2026-10-21
35
Trellis Bioscience raises $1.35M in indefinite biotech offering under Reg D 506(b)
Company raise · Open-ended · Offering Indefinite · Sold $1.4M · REDWOOD CITY, CA · filed 2026-10-21
35
Trellis Bioscience raises indefinite capital under Reg D 506(b) in Redwood City
Company raise · Open-ended · Offering Indefinite · Sold $985K · REDWOOD CITY, CA · filed 2026-10-21